Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for ...

2024 Healthcare & Pharmaceuticalscategory US FDA declines full approval for Intercept's liver disease drug November 12, 2024 Healthcare & Pharmaceuticalscategory Novavax cuts 2024 revenue forecast ...

Novavax’s COVID-19 vaccine produced higher levels of neutralising antibodies than produced by recovered patients in an early trial, paving the way for a phase 3 trial and potential approval by ...

Earlier in October, the European Commission approved Novavax's updated 2024-2025 Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2705), dispersion for injection, for use in ...

The phase 3 trial – which takes Novavax’ NVX‑CoV2373 shot a step closer to approval – also found that it was 100% effective in preventing severe COVID-19. Novavax has said it intends to ...

Novavax cut its annual revenue forecast on ... Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making ...

Biden’s approval dips to lowest of presidency ... Report with Amy Walter join Judy Woodruff to discuss the latest political news, including progress on President Joe Biden’s Build Back ...

The latest figures include 22% who Strongly Approve of the job Biden is doing and 43% who Strongly Disapprove. This gives him a Presidential Approval ... on events in the news and other topics ...

A bill that would mandate the sale within six months or see TikTok facing a ban was approved by a US congressional ... The proposed legislation represents the latest attempt by American lawmakers ...